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ladder outlet obstruction (BOO),  such as 
benign prostatic hyperplasia (BPH),  is a com-
mon disorder,  aﬀ ecting 50ｵ to 80ｵ of males over 
the age of 50 [1].  It causes various urinary symp-
toms ; it leads to irritability,  urgency,  urge inconti-
nence due to detrusor hyperreﬂ exia in the storage 
phase,  hesitancy and weak ﬂ ow in the voiding phase 
with consequent retention in the end phase. 
Furthermore,  BOO causes compensatory bladder 
smooth muscle hypertrophy that aggravates various 
urinary dysfunctions [1].  Previous studies show that 
BOO increases the activation of some molecules in 
the bladder smooth muscle,  for example,  nuclear fac-
tor κB (NF-κB) [2],  c-Jun NH2-terminal kinase 
(JNK) [3],  cyclooxygenase-2 (COX-2) [4],  basic 
ﬁ broblast growth factor (bFGF) [5] and calcineurin 
[6].  However,  the cellular and molecular mecha-
nisms of BOO-induced bladder smooth muscle hyper-
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We examined the involvement of the signal transducer and activator of transcription 3 (STAT3) in 
bladder outlet obstruction (BOO)-induced bladder smooth muscle hypertrophy using a rat in vivo and 
in vitro study.  BOO induced increases in bladder weight and bladder smooth muscle thickness 1 week 
after the operation.  By using antibody microarrays,  64 of 389 proteins blotted on the array met our 
selection criteria of an INR value between ｧ 2.0 and ｦ 0.5.  This result revealed up-regulation of tran-
scription factors,  cell cycle regulatory proteins,  apoptosis-associated proteins and so on.  On the 
other hand,  down-regulation (INR value ｦ 0.5) of proteins was not found.  In a proﬁ ling study,  we 
found an increase in the expression of STAT3.  A signiﬁ cant increase in nuclear phosphorylated 
STAT3 expression was conﬁ rmed in bladder smooth muscle tissue by immunohistochemistry and 
Western blot analysis.  Cyclical stretch-relaxation (1 Hz) at 120ｵ elongation signiﬁ cantly increased the 
expression of STAT3 and of ｸ-smooth muscle actin in primary cultured bladder smooth muscle cells. 
Furthermore,  the blockade of STAT3 expression by the transfection of STAT3 small interfering 
RNA (siRNA) signiﬁ cantly prevented the stretch-induced increase in ｸ-smooth muscle actin expres-
sion.  These results suggest that STAT3 has an important role in the induction of bladder smooth 
muscle hypertrophy.
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trophy are still obscure.
　　Antibody microarray provides a powerful analyti-
cal technique for high-throughput proﬁ ling protein 
expression.  It is useful for screening protein expres-
sion by measuring expression levels of abundant pro-
teins simultaneously and semi-quantitatively with a 
single experiment [7].  To elucidate molecular events 
involved in bladder smooth muscle hypertrophy fol-
lowing BOO,  protein expression was proﬁ led in the 
bladder tissue of a rat BOO model that showed 
smooth muscle hypertrophy by using antibody micro-
arrays as a preliminary screening study.  Among the 
molecules up-regulated by BOO in the antibody 
microarray assay,  we focused on the role of the sig-
nal transducer and activator of transcription 3 
(STAT3) that is related to inﬂ ammatory reaction and 
cytokine signals.  In the present study,  we examined 
the involvement of STAT3 in bladder smooth muscle 
hypertrophy using an in vivo BOO model,  and we 
examined mechanical stretch stress on primary cul-
tured bladder smooth muscle cells by inhibiting 
STAT3 expression through transfection of its small 
interfering RNA (siRNA).
Materials and Methods
　　Surgical induction of rat BOO models.　 All 
animal procedures described in this report were in 
strict accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory 
Animals (NIH,  Bethesda,  MD,  USA) and with the 
Guideline for Animal Experiments of Okayama 
University Advanced Science Research Center.  The 
partial BOO rat model was prepared by a previously 
described procedure [6].  Eight-week-old female 
Sprague-Dawley rats weighing 180 to 200 g were 
used in the surgical induction of rat BOO models. 
The rats were sacriﬁ ced 1 week after the surgery to 
remove the whole bladder.  After observation and 
weighing,  the bladder tissue was used in the follow-
ing experiments.
　　Protein extraction from bladder tissue.
The bladder mucosa was removed from the bladder 
tissue with a pair of scissors,  and then the remaining 
tissue,  including bladder smooth muscle,  was frozen 
in liquid nitrogen.  The frozen tissue was broken with 
a hammer.  The samples were homogenized with 
300 ｻl of ice-cold RIPA buﬀ er (50 mM Tris-HCl (pH 
7.5),  250 mM sucrose,  75 mM urea,  60 mM ｹ-mer-
captoethanol,  5ｵ sodium dodecyl sulfate (SDS)) plus 
a proteinase inhibitor using a Polytron homogenizer 
(model PT 1200) at maximum speed for 6 bursts of 
10ﾝ30 sec each.  After incubation on ice for 30 min, 
the homogenates were centrifuged (16,000 g × 20 min 
at 4 °C),  and then the supernatants were obtained as 
total cell lysates.  The protein concentration of 
lysates was measured by protein assay reagents (RC 
DC Protein Assay reagents ; Bio-Rad Laboratories, 
Hercules,  CA,  USA).
　　Antibody microarray.　 Protein lysate labeling 
with ﬂ uorescent dye and protein expression proﬁ ling 
were performed using antibody microarrays (BD 
Clontech Ab Microarray 380,  #K1847ﾝ1,  BD 
Biosciences Clontech,  Palo Alto,  CA,  USA) accord-
ing to the manufacturer’s instructions.  Each 450 ｻl 
of 1.1 mg/ml protein lysate from the bladder after 
BOO or sham operation was labeled with 50 ｻl of 
Cy3 or Cy5 ﬂ uorescent dye (Amersham Biosciences, 
Arlington Heights,  IL,  USA) with incubation at 4 °C 
for 90 min.  Each antibody microarray glass slide was 
incubated with either of the labeled protein mixtures 
(BOO-Cy5 ＋ sham-Cy3 or sham-Cy5 ＋ BOO-Cy3) at 
room temperature for 30 min.  The Cy5/Cy3 ﬂ uores-
cent signal ratios for all coordinates on each array 
(ratio BOO-Cy5/sham-Cy3 or ratio sham-Cy5/
BOO-Cy3) were calculated with array analysis soft-
ware (GenePix Pro).  The change in the protein 
expression of each coordinate on the array was evalu-
ated by the internally normalized ratio (INR) : the 
square root of (ratio BOO-Cy5/sham-Cy3)/(ratio 
sham-Cy5/BOO-Cy3).
　　Primary culture of rat bladder smooth mus-
cle cells.　 Under deep sodium pentobarbital anes-
thesia (80 mg/kg,  i.p.),  the bladder was removed 
from female Sprague-Dawley rats (10 weeks of age) 
and rinsed with 10 mM phosphate buﬀ ered saline 
(PBS).  After the urothelium was removed,  the blad-
der was incubated with 0.2ｵ trypsin in RPMI-1640 
medium (Invitrogen,  Carlsbad,  CA,  USA) for 30 min 
at 37 °C.  After centrifugation for 5 min at 2,000 rpm, 
the precipitated bladder was minced into small 
pieces.  The minced bladder tissue was incubated 
with 0.1ｵ collagenase in RPMI-1640 medium for 
30 min at 37 °C and centrifuged for 5 min at 2,000 rpm, 
after which the pellet was suspended into culture 
medium RPMI-1640 containing 10ｵ fetal bovine 
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serum,  1ｵ penicillin and streptomycin.  The cells 
(5,000 cells/mm2) were seeded in culture dishes and 
cultured in the culture medium in a humidiﬁ ed 5ｵ 
CO2ﾝ95ｵ air atmosphere at 37 °C.
　　Application of cyclical stretch-relaxation to 
cultured bladder smooth muscle cells.
Cultured bladder smooth muscle cells were removed 
from the dish with 0.02ｵ trypsin in PBS and were 
transferred onto a 10.24 cm2 collagen-coated silicone 
chamber at a density of 5 × 105 cells/cm2 in the cul-
ture medium.  The silicon chamber had a 200-
ｻm-thick transparent bottom center,  and the bottom 
corner was 400 ｻm thick to prevent narrowing at its 
bottom center.  The silicone chamber was attached to 
a cell-stretching apparatus (NS-500,  Strex,  Nagoya, 
Japan) that was driven by a computer-controlled step-
ping motor.  After cells were allowed to attach to the 
chamber bottom for 24 h,  a uni-axial sinusoidal 
stretch (120ｵ peak to peak,  at 1 Hz) was applied at 
37 °C in a humidiﬁ ed 5ｵ CO2ﾝ95ｵ air atmosphere. 
Attached bladder smooth muscle cells were subjected 
to stretch/relaxation for various durations up to 
24 h.
　　Blocking STAT3 expression by RNA inter-
ference methods.　 To examine the eﬀ ects of 
inhibiting STAT3 expression on bladder smooth 
muscle hypertrophy,  RNA interference for STAT3 
was performed on cultured bladder smooth muscle 
cells attached to the silicone chamber in advance of 
the stretch stimuli using the Silencer siRNA 
Transfection Kit (Ambion,  Austin,  Texas,  USA) 
according to the manufacturer’s instructions.  Before 
the siRNA transfection,  bladder smooth muscle cells 
plated on a collagen-coated silicone chamber at a den-
sity of 5 × 105 cells/cm2 were cultured in culture 
medium with 10ｵ fetal bovine serum.  The siRNA 
for STAT3 (Silencer Validated siRNA STAT3, 
Ambion,  Austin,  Texas,  USA) at a ﬁ nal concentra-
tion of 100 nM pre-incubated with siPORT Lipid 
(Ambion) in serum-free medium for 20 min was added 
onto the cells and then incubated in culture medium 
for another 1 h to transfect the siRNA.  After the 
addition of fresh culture medium to the serum,  cells 
were cultured for 24 h and then challenged with the 
cyclical stretch relaxation described above. 
Scrambled control siRNA having no signiﬁ cant 
homology to rat gene sequences were used as nega-
tive control siRNA in the present study.
　　Protein extraction from cultured bladder 
smooth muscle cells.  Cultured bladder smooth 
muscle cells after the stretch were washed with 
10 mM PBS and then lysed in 100 ｻl of ice-cold 
RIPA buﬀ er 1 mM PBS (pH 7.4),  1ｵ Nonidet P-40, 
0.5ｵ sodium deoxycholate,  0.1ｵ SDS plus a pro-
teinase inhibitor (0.1 mg/ml phenylmethylsulfonyl ﬂ u-
oride).  After incubation on ice for 60 min,  the 
homogenates were centrifuged (16,000 g × 20 min at 
4 °C),  and then the supernatants were obtained as 
total cell lysates.
　　Western blot analysis.　 Western blot analysis 
was performed as described previously [6,  8].  The 
total cell lysate (50 ｻg) from the samples was mixed 
with the sampling buﬀ er (4ｵ SDS,  0.02ｵ bromo-
phenol blue,  20ｵ glycerol,  and 10ｵ ｹ-mercaptoeth-
anol in 125 mM Tris-HCl,  pH 6.8) and boiled.  The 
proteins were separated on 10ｵ or 12.5ｵ SDS-
polyacrylamide gels.  Blots were incubated with 
mouse monoclonal antibodies against STAT3 (diluted 
1 : 2,500 ; BD Biosciences),  ｸ-smooth muscle actin 
(1 : 400 ; Sigma-Aldrich,  St.  Louis,  MO,  USA), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
1 : 100 ; Chemicon,  Temecula,  CA,  USA),  rabbit 
polyclonal anti-phospho-STAT3 (Tyr705) antibody 
(diluted 1 : 1,000 in PBST ; Cell Signaling 
Technology,  Boston,  MA,  USA),  anti-NF-κB anti-
body (1 : 200 ; Santa Cruz Biotechnology,  Santa 
Cruz,  CA,  USA),  anti-phospho-NF-κB p65 (Ser536) 
antibody (diluted 1 : 1,000 in PBST ; Cell Signaling 
Technology),  and bFGF (1 : 500 ; R&D Systems, 
Minneapolis,  MN,  USA).  The blots were then 
reacted with donkey anti-mouse IgG (Chemicon).
　　Morphological observation of bladder tissue 
slice.　 One week after the surgical induction of 
BOO models,  rats were transcardially perfused with 
saline followed by a ﬁ xative containing 4ｵ parafor-
maldehyde and 0.35ｵ glutaraldehyde in 0.1 M phos-
phate buﬀ er (PB,  pH 7.4) under deep anesthesia. 
After the perfusion,  the whole bladder was removed, 
post-ﬁ xed for 24 h in a ﬁ xative containing 4ｵ para-
formaldehyde in 0.1 M PB (pH 7.4),  and then cryo-
protected in 15ｵ sucrose in PB for 48 h.  The blad-
der tissue frozen with powdered dry ice was cut into 
10-ｻm-thick slices by a cryostat.  Some slices of 
bladder tissue were ﬁ xed and stained with hematoxy-
lin-eosin.  The thickness of the bladder wall and 
smooth muscle layer was evaluated using computer-
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ized image analysis software (NIH Image 1.56) run on 
a Macintosh computer.  Within each bladder slice, 
the smooth muscle layer was outlined with a screen 
cursor driven by a hand-held mouse.  Relative size 
units were then measured.
　　For the immunohistochemistry of phosphorylated 
STAT3,  the sections were soaked in 0.5ｵ H2O2 in 
10 mM PBS containing 0.2ｵ Triton X-100 (PBST) 
for 30 min and then incubated in 1ｵ normal goat 
serum in PBST for 30 min at room temperature. 
After washing with PBST (3 × 10 min),  the sections 
were exposed to anti-phospho-STAT3 (Tyr705) rab-
bit polyclonal antibody (diluted 1 : 100 in PBST ; Cell 
Signaling) for 18 h at 4 °C.  After incubation with the 
primary antibody,  sections were washed for 
5 × 5 min in PBST before being incubated with bioti-
nylated goat anti-rabbit IgG secondary antibody 
(diluted 1 : 200 in PBST : Vector Laboratories, 
Burlingame,  CA,  USA) for 2 h at room temperature. 
Following washes in PBST (3 × 10 min),  the sections 
were incubated with the avidin-biotin peroxidase com-
plex (diluted 1 : 250) for 1 h.  Phosphorylated 
STAT3-immunopositive cells were visualized by 3,3’
-diaminobenzidine,  nickel,  and H2O2 and counter-
stained with eosin.  Phosphorylated STAT3-
immunoreactive cells in the bladder section were 
counted manually on 16ﾝ18 slices per group using a 
microscope at a magniﬁ cation of X200 with a super-
imposed grid.  Counting was performed blindly.
　　Immunohistochemistry of cultured bladder 
smooth muscle cells.　 Immunohistochemistry of 
cultured bladder smooth muscle cells was performed 
as described previously [6].  Brieﬂ y,  cultured blad-
der smooth muscle cells after the stretch stimuli on 
the silicone chamber were ﬁ xed with 4ｵ paraformal-
dehyde in 0.1 M phosphate buﬀ er.  The cell culture 
chambers were incubated with mouse monoclonal 
anti-ｸ-smooth muscle actin primary antibody (diluted 
1 : 200 ; Sigma-Aldrich).  After a wash,  the cell sam-
ples were reacted with ﬂ uorescein isothiocyanate 
(FITC)-conjugated secondary antibodies (diluted 
1 : 200 ; Chemicon).  Immunoﬂ uorescence signals were 
analyzed under a ﬂ uorescence microscope (BX50-
FLA,  Olympus,  Tokyo,  Japan).  The relative den-
sity of the immunoﬂ uorescence signals was assessed 
using the microscope at a magniﬁ cation of X400 and 
Macintosh computer-based image analysis systems 
(NIH Image 1.56).
　　Statistical analyses.　 Results are given as 
means ± SEM values.  Statistical analyses of the data 
were performed using Student’s t-test or one-way 
analysis of variance (ANOVA) followed by post-hoc 
Fisher’s PLSD test.  A p value less than 0.01 
denoted the presence of a statistically signiﬁ cant dif-
ference.
Results
　　Bladder weight and morphological change 
in the bladder smooth muscle in rat BOO 
model.　 BOO induced a marked increase in blad-
der weight (BOO,  215.8 ± 24.8 mg ranging from 118 
to 335 mg vs.  controls,  60.5 ± 5.11 mg ranging from 
30 to 77 mg) at 1 week after the operation (Fig.  1A). 
Histological observation revealed an increase in the 
thickness of the bladder smooth muscle layer 1 week 
after BOO,  although there was no inﬁ ltration of con-
nective tissue or inﬂ ammatory cells among the muscle 
cells (Fig.  1B).
　　Antibody microarrays.　 As a preliminary 
screening,  we performed a proﬁ ling of BOO-induced 
protein expression in the bladder smooth muscle by 
using the antibody microarray.  When protein expres-
sion in the rat bladder tissue was screened 1 week 
after BOO by using antibody microarrays,  64 of 389 
proteins blotted on the array met our selection crite-
ria,  which was an INR value between ｧ 2.0 and 
ｦ 0.5.  The antibody microarray approach revealed 
up-regulation of transcription factors,  cell cycle-reg-
ulatory proteins,  apoptosis-associated proteins,  cyto-
skeletal proteins,  adhesion molecules,  growth factor- 
and stress-related proteins,  signal transduction-
related proteins,  and nitric oxide-related proteins in 
the bladder tissue 1 week after the BOO operation 
(Table 1).  To a lesser extent,  NF-κB and Fos (AP-1) 
were also up-regulated.  INR values were 1.85 and 
1.25,  respectively.
　　Changes in STAT3,  bFGF,  NF-κB, and 
ｸ-smooth muscle actin expression in smooth 
muscle after BOO.　 In the proﬁ ling study using 
the antibody microarray,  we found a marked increase 
in the expression of acute phase response factor 
STAT3 in rat bladder smooth muscle tissue after the 
BOO operation.  In the present study,  therefore,  we 
focused on the involvement of the inﬂ ammatory fac-
tor STAT3 in bladder smooth muscle hypertrophy 
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following BOO.  Immunohistochemistry of STAT3 in 
rat bladder sections showed marked and constitutive 
expression of phosphorylated STAT3 (activated 
form) in the nuclei of bladder mucosal epithelial cells 
of both control and BOO animals (Fig.  1 C).  The 
apparent expression of the nuclear phosphorylated 
STAT3 was revealed 1 week after BOO,  although 
there was little induction of STAT3 in the bladder 
smooth muscle cells of the sham-operated control 
group (Fig.  1 C).  The number of phosphorylated 
STAT3-immunopositive cells signiﬁ cantly increased 
in the bladder smooth muscle layer of BOO rats, 
compared with sham-operated controls (Fig.  1D).
　　In Western blot analysis,  signiﬁ cant increases in 
the expression of STAT3 and its activated form of 
phosphorylated STAT3 were conﬁ rmed in the lysate 
from rat bladder smooth muscle tissue 1 week after 
BOO (Fig.  2A & 2B).  This is consistent with the 
antibody array results.  It was also revealed that the 
expression of bFGF,  NF-κB,  and its activated form, 
phosphorylated NF-κB p65,  all of which were previ-
ously reported to be elevated following BOO [2,  5], 
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Fig. 1　　Smooth muscle hypertrophy and histological changes after partial BOO.  A,  Changes in bladder weight 1 week after BOO. 
Value shows mean bladder weight ± SEM in 10 rats per group.  ＊p ＜ 0.01 vs.  sham-operated control group ; B,  Morphological changes 
in bladder section 1 week after the operation in sham-operated control group and BOO group (hematoxylin-eosin staining).  Scale bar 
indicates 50 µm ; C,  Immunohistochemistry of phosphorylated STAT3 in bladder slice 1 week after BOO with light eosin counterstaining.
Dark gray signals (arrows) are representative phosphorylated STAT3-immunopositive nuclei.  Scale bar ＝ 50 µm ; D,  Quantitative analysis 
of number of phosphorylated STAT3-immunopositive cells in the bladder smooth muscle layer after BOO.  Value shown is the mean 
number of phosphorylated STAT3-immunopositive cells ± SEM (number/mm2 on 16ﾝ18 slices/group).  ＊p ＜ 0.01 vs.  sham-operated 
control group.
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Table 1　　Proﬁ ling of protein expression in the bladder tissue 1 week after BOO by using antibody microarray.
Up-regulated proteins which corresponding INR values on the array were ｧ2.0 were evaluated the proteins were more abundant in BOO 
group than sham-operated group.
Category/Protein INR Swiss Prot Function
Transcription factors
　E2F-1 2.15 Q01094 Transcription factor as a determinant of the G1/S-phase transition
　STAT3 2.10 P40763 Signal transducer and activator of transcription 3 (Acute-phase response factor)
　M33 2.10 P30658 Chromatin regulator
　Per2 2.08 O15055 Regulate the circadian cycle via transcriptional control
　TFⅡ-1/BAP-135 2.07 O15359 General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated 
protein-135) (BTK-associated protein-135) (BAP-135)
　IKKｺ/3/NEMO 2.04 Q9Y6K9 NF-κB essential modulator
　IKKｸ/1 2.04 O15111 Inhibitor of NF-κB kinase alpha subunit
　LXR 2.00 Q13133 Orphan receptor regulation of cholesterol homeostasis
Cell cycle regulatory proteins
　CDC27 2.30 P30260 Cell division cycle protein 27 homolog
　AIM-1 2.21 C60446 Serine/threonine protein kinase 12
　SRPK1 2.17 Q12890 Phosphorylation of SR proteins during the cell cycle
　DBP2 2.15 O60231 Putative pre-mRNA splicing factor RNA helicase
　DNA polymerase δ 2.15 P28340 DNA polymerase delta catalytic subunit as polymerase and exonuclease
　cdk1 2.10 P06493 Control of the eukaryotic cell cycle
　XIN 2.08 Q8TCG7 Hypothetical protein
　NEK2 2.06 P51955 Serine/threonine-protein kinase NEK2
　CDC25 C 2.00 P30307 Dosage-dependent inducer in mitotic control
　Cyclin D1 2.00 P24385 Essential for the control of the cell cycle at the G1/S (START) transition
Apotosis-associated proteins
　Caspase7/Mch3 2.41 P55210 Caspase-7 precursor (ICE-like apoptotic protease 3) (ICE-LAP3)
　DDX1 2.15 Q92499 ATP-dependent helicase DDX1
　MEK 5 2.08 Q92961 Mitogen-activated protein kinase kinases
　GOK/Stim1 2.06 Q13586 Stromal interaction molecule 1 precursor as possible adhesion molecule in early 
hematopoiesis
　IKKｺ/3/NEMO 2.04 Q9Y6K9 NF-κB essential modulator
　IKKｸ/1 2.04 O15111 Inhibitor of NF-κB kinase alpha subunit
　XPA 2.02 P23025 DNA-repair protein complementing XP-A cells
　hILP/XIAP 2.02 P98170 Apoptotic suppressor.  Inhibitor of caspase-3,  -7 and -9
　Ku-80 2.00 P13010 Single stranded DNA-dependent ATP-dependent helicase
Oncogenes & tumor suppressors
　c-Myc 2.09 P01106 Myc proto-oncogene protein in the regulation of gene transcription,  especially 
growth-related gene transcription
　erbB-2/HER-2 2.08 P04626 Receptor protein-tyrosine kinase erbB-2 precursor (C-erbB-2) (Tyrosine kinase-type 
cell surface receptor HER2) (MLN 19)
　eIF-5 2.03 P55010 Eukaryotic translation initiation factor 5
　eIF-4ｺ 2.02 Q04637 Eukaryotic translation initiation factor 4 g
　HPV-16 L1 2.01 P03101 Human papillomavirus type 16
Cytoskeletal proteins
　Myogenin 2.08 P15173 Myogenic factor Myf-4 involved in muscle diﬀ erentiation
　Cypher1 2.05 O75112 Adaptor that couples PKC-mediated signaling to the cytoskeleton in striated muscle
　Tensin 2.04 Q9HBL0 Inﬂ uenced actin ﬁ lament organization
　Moesin 2.04 P26038 Involved in connections of major cytoskeletal structures to the plasma membrane
　ABP-280 2.02 P21333 Endothelial actin-binding protein
　MAP4 2.01 P27816 Non-neuronal microtubule-associated protein
　Myr6 2.01 Q9ULV0 Myosin Vb
　SCP3 2.00 P70281 Component of the transverse ﬁ laments of synaptonemal complexes
305Involvement of STAT3 in BOODecember 2006
Category/Protein INR Swiss Prot Function
Adhesion molecules
　Fibronectin 2.09 P02751 Role in cell adhesion,  morphology,  and surface architecture
　Cadherin-5 2.09 P33151 Calcium dependent cell adhesion protein
　Kalinin B1 2.05 Q13751 Binding to cells via a high aﬃ  nity receptor
　Neuroglycan C 2.01 O95196 Neural transmembrane chondroitin sulfate proteoglycan
Growth factor- & stress-related proteins
　HAX-1 2.15 O00165 HS1-binding protein
　HS1 2.11 P14317 Substrate of the antigen receptor-coupled tyrosine kinase
　TGF-ｹ1 2.10 P01137 Transforming growth factor ｹ1 precursor that controls proliferation and 
diﬀ erentiation
　COX-2/PGHS 2.04 P35354 Prostaglandin G/H synthase 2 precursor
　Neuropilin-2 2.02 O60462 Vascular endothelial cell growth factor 165 receptor 2
Signal transduction-related proteins
　AIM-1 2.21 C60446 Serine/threonine protein kinase 12
　SRPK1 2.17 Q12890 Phosphorylation of SR proteins during the cell cycle
　AKAP149 2.11 Q92667 A-kinase anchor protein 149 kDa that anchors regulatory subunits of 
protein kinase A to the mitochondorial outer membrane
　Rho-GDI 2.11 P52565 Regulate the GDP/GTP exchange reaction of the Rho proteins
　CaM Kinase Kinase 2.10 Q9BQH3 Upstream regulator in the Ca2＋/CaM-dependent neural processes
　Calretinin 2.10 P22676 Promote calcium homeostasis by acting as buﬀ ers of intracellular Ca2＋
　MEK 5 2.08 Q92961 Mitogen-activated protein kinase kinases
　erbB-2/HER-2 2.08 P04626 Receptor protein-tyrosine kinase erbB-2 precursor (C-erbB-2) (Tyrosine 
kinase-type cell surface receptor HER2) (MLN 19)
　NEK2 2.06 P51955 Serine/threonine-protein kinase NEK2
　SPA-1 2.04 O60484 Signal-induced proliferation-associated protein 1 ; GTPase activator for 
the nuclear Ras-related regulatory proteins Rap1 and Rap2
　CPG16/CaM Kinase Ⅵ 2.02 O15075 Serine/threonine-protein kinase DCAMKL1 (Doublecortin-like and CAM 
kinase-like 1) that may be involved in a calcium-signaling pathway
　IQGAP1 2.02 P46940 Bind to activated CDC42 and associate with calmodulin
NO-related proteins
　iNOS/TYPE Ⅱ 2.10 P35228 Inducible nitric oxide synthase (iNOS)
　nNOS 2.08 P29475 Neuronal nitric-oxide synthase,  brain (nNOS)
　Arginase Ⅰ 2.01 P05089 Catalyze the last step of Urea cycle ; Arginine metabolism (Liver type)
Nuclear
　DDX1 2.15 Q92499 ATP-dependent helicase DDX1
　AF6 2.11 P55196 Chromosomal translocation
　Chromogranin A 2.05 P10645 Protein costored and coreleased with catecholamines
　XPA 2.02 P23025 DNA-repair protein complementing XP-A cells
Organelle
　SNX2 2.10 O60749 Interact with a variety of receptor types in protein transport
　GM130 2.06 Q9NYF9 Golgi structural protein
　ERp72 2.01 P13667 Protein disulﬁ de isomerase A4 precursor
Neuroscience
　SH2-B 2.13 Q9NRF1 Signaling molecules in tyrosine kinase receptor pathways
　Apo E 2.11 P02649 Main apoprotein of the chylomicron
was signiﬁ cantly increased after the BOO operation 
(Fig.  2A & 2B).  The expression of ｸ-smooth muscle 
actin,  which is known as a speciﬁ c protein in smooth 
muscle,  also signiﬁ cantly increased following BOO 
(Fig.  2A & 2B).
　　Changes in STAT3 and α-smooth muscle 
actin expression in bladder smooth muscle 
cells after cyclical stretching and eﬀ ects of 
transfection of siRNA for STAT3.　 Changes 
in the STAT3 expression in primary cultured blad-
der smooth muscle cells were examined during the 
stress of cyclical stretching.  Western blot analysis 
revealed that STAT3 expression was signiﬁ cantly 
increased by a 3-h stretch compared with non-
stretched controls.  The expression gradually 
decreased from the 6-h to the 24-h stretch.  In con-
trast,  ｸ-smooth muscle actin expression gradually 
increased from the 3-h to the 24-h stretch (Fig.  3A 
& 3B).
　　The STAT3 expression was greatly reduced by 
the transfection with STAT3 siRNA,  but not with 
the scrambled control siRNA (Fig.  4A).  The trans-
fection reagent or scrambled control siRNA showed 
no eﬀ ects on cell viability in the present study (data 
not shown).  Immunohistochemical study revealed that 
ｸ-smooth muscle actin was strongly expressed in cul-
tured bladder smooth muscle cells after the 24-h 
stretch compared with that in non-stretched controls 
(Fig.  4B).  Interestingly,  the transfection of STAT3 
siRNA signiﬁ cantly inhibited the increase of 
ｸ-smooth muscle actin expression induced by the 24-h 
stretch (Fig.  4B & 4 C),  although the transfection 
with control siRNA showed no eﬀ ects of the stretch-
induced increase in ｸ-smooth muscle actin.
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Fig. 2　　Changes in STAT3,  bFGF,  NF-κB,  and ｸ-smooth muscle actin expression in bladder smooth muscle after BOO. 
Representative Western blots for STAT3,  phosphorylated STAT3,  bFGF,  NF-κB,  phosphorylated NF-κB p65,  and ｸ-smooth muscle 
actin,  and corresponding signals of GAPDH (A).  Quantitative analyses of the relative density of detected signals on the blots for STAT3, 
phosphorylated STAT3,  bFGF,  NF-κB,  phosphorylated NF-κB p65,  and ｸ-smooth muscle actin (B).  The value is the mean of the ratio 
for each detected protein/GAPDH (relative density) ± SEM.  ＊p ＜ 0.05,  ＊＊p ＜ 0.01 vs.  sham-operated control group.
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Fig. 4　　Eﬀ ects of transfection of siRNA for STAT3 on increases in ｸ-smooth muscle actin expression induced by a 24-h stretch in pri-
mary cultured bladder smooth muscle cells.  Western blot analyses conﬁ rm the marked reduction of STAT3 expression by the transfection 
with STAT3 siRNA but not with scrambled control siRNA (A).  Immunoﬂ uorescence staining for ｸ-smooth muscle actin after the 24-h 
cyclical stretch and the eﬀ ects of pretreatment with siRNA for STAT3 (B).  Negative control means staining without the primary antibody. 
Scale bar ＝ 50 µm.  Relative density of ﬂ uorescence signals for ｸ-smooth muscle actin (C).  Data are shown as means of relative 
density ± SEM.  ＊p ＜ 0.01 between the 2 indicated groups.
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Fig. 3　　Changes in STAT3 and ｸ-smooth muscle actin expression in bladder smooth muscle cells after cyclical stretching. 
Representative Western blots for STAT3 and ｸ-smooth muscle actin (A).  Quantitative data of STAT3 and ｸ-smooth muscle actin expres-
sion (B).  Values are means of the ratio for each detected protein/GAPDH (relative density) ± SEM.  ＊p ＜ 0.01 compared with the non-
stretched control group.
Discussion
　　The present study was designed to provide a pro-
ﬁ le of BOO induced protein expression in the rat 
bladder smooth muscle by using an antibody microar-
ray.  BOO induced protein expression of 64 kinds of 
molecules,  including transcription factors,  cell cycle-
regulatory proteins,  apoptosis-associated proteins, 
cytoskeletal proteins,  adhesion molecules,  growth 
factor- and stress-related proteins,  signal transduc-
tion-related proteins,  and nitric oxide-related pro-
teins in the bladder tissue.  Among those molecules 
up-regulated by BOO detected by the antibody micro-
array,  previous studies showed increases in the 
expression of some molecules in the bladder smooth 
muscle after BOO ; these molecules are related to 
NF-κB [2] or COX-2 [4].  Several studies indicate 
that the transcription factor,  activator protein-1 
(AP-1),  is involved in the development of bladder 
smooth muscle hypertrophy [2,  9,  10].  In this 
microarray analysis,  AP-1 was also up-regulated 
(INR ＝ 1.25).  In the proﬁ ling study using an antibody 
microarray,  we newly found a marked increase in the 
expression of acute phase response factor STAT3 in 
rat bladder tissue after the BOO operation,  which 
was conﬁ rmed by Western blot analysis.
　　STAT3 was originally identiﬁ ed as a molecule 
responsible for cytokine signaling in the interleukin-6 
family system [11].  Stimulation of glycoprotein 130 
(gp130),  a common subunit of the interleukin-6 family 
cytokine receptor,  leads to activation of JNK,  which 
phosphorylates STAT3 on the tyrosine residue.  It 
was reported that STAT3 plays a crucial role in the 
regeneration or remodeling of tissue in vivo [12].  In 
cardiac myocytes,  the STAT3 signaling pathway is 
activated by extracellular stress,  including catechol-
amine stress and mechanical stretching [13].  Recent 
studies show that the expression of STAT3 in car-
diomyocytes regulates cardiac hypertrophy and angio-
genesis [14].  The present results clearly show that 
STAT3 expression,  especially activated phosphory-
lated STAT3,  was induced in the bladder smooth 
muscle after the BOO model in vivo.
　　BOO leads to progressive wall distension caused 
by the incomplete emptying of urine,  thereby result-
ing in increased local stretching of bladder smooth 
muscle cells.  Mechanical stretch stress is thought to 
trigger responses in the overloaded bladder.  Several 
studies using an in vitro model of mechanical stress 
demonstrate that repetitive stretch stimulation of 
bladder smooth muscle cells results in increased 
expression of a variety of growth factors and other 
speciﬁ c proteins [15,  16].  The suitable conditions 
for mechanical stretching remain unclear.  In this 
study,  we identiﬁ ed the increase of STAT3 expres-
sion,  consistent with the BOO in vivo model,  at 1 Hz 
and 20ｵ elongation,  which indicated faster stimula-
tion than was found in previous reports [2,  16].  To 
identify a mechanistic link between mechanical stimu-
lation and growth of the bladder muscle,  some 
groups have investigated the expression of known 
smooth muscle cell mitogens and other growth regu-
latory molecules in bladder smooth muscle cells fol-
lowing overdistension secondary to bladder outlet 
obstruction in vivo or in repetitive mechanical stimu-
lation in vitro [9,  17].  Adam et al.  reported that 
mechanical stimulation of bladder smooth muscle 
cells in vitro and whole bladder distension ex vivo 
resulted in qualitatively similar patterns of gene 
expression [9].  We conﬁ rmed the elevation in 
STAT3 expression in cultured bladder smooth mus-
cle cells during the stress of cyclical stretching. 
Furthermore,  we examined the correlation between 
STAT3 expression and the development of bladder 
smooth muscle hypertrophy,  corresponding to the 
expression of a smooth-muscle-speciﬁ c marker, 
ｸ-smooth muscle actin,  with or without the blockade 
of STAT3 expression using siRNA.  The siRNA is a 
short,  double-stranded RNA molecule that can target 
complementary mRNA for degradation via a cellular 
process termed RNA interference [18].  Recently, 
siRNA has emerged as a powerful RNAi reagent for 
directed posttranscriptional gene silencing and inhibi-
tion of viral propagation [19].  In the present study, 
we demonstrated that the blockade of STAT3 
expression by the STAT3 siRNA suppresses bladder 
smooth muscle hypertrophy,  representing an increase 
in ｸ-smooth muscle actin expression following 
mechanical stretch stress.  The present results pro-
vide evidence that STAT3 signaling may play an 
important role in the induction of bladder smooth 
muscle hypertrophy.  Further studies to understand 
the molecular biology related to STAT3 following 
BOO could lead to an eﬀ ective gene-modulating ther-
apy for obstructed bladder.
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309Involvement of STAT3 in BOODecember 2006
　　In the article by Fujita Oｴｳ  et alｴ  entitled “Involvement of STAT3 in Bladder Smooth Muscle 
Hypertrophy Following Bladder Outlet Obstruction"ｳ  which appeared in the December 2006 issueｳ 
Volｴ  60ｳ  Noｴ  6ｳ  pp 299ﾝ309ｳ  a correction should be noted in the last line of Western blot analysis on page 301ｴ
Error :
reacted with donkey anti-mouse IgG (Chemicon).
Correction :
reacted with donkey anti-mouse IgG (Chemicon) or donkey anti-rabbit IgG secondary antibodies (Amersham 
Biosciences) at room temperature for 1 hｴ  Speciﬁ c signals of proteins were visualized by chemiluminescence 
using the ECL Western blotting detection kit (Amersham Biosciences)ｴ  The relative density of detected sig-
nals on the blots was measured and analyzed with image scanner and image analysis software (NIH image 
1.56)ｴ  For quantitative analysisｳ  the ratio for detected protein (relative density) and the constitutively 
expressed GAPDH protein was calculated to normalize for loading and transfer of artifacts introduced in 
Western blottingｴ
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